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ABSTRACT
A simple method for the detection of sequence- and
structural-selective ligand binding to nucleic acids
is described. The method is based on the commonly
used thermal denaturation method in which ligand
binding is registered as an elevation in the nucleic
acid melting temperature (Tm). The method can be
extended to yield a new, higher -throughput, assay
by the simple expediency of melting designed mix-
tures of polynucleotides (or oligonucleotides) with
different sequences or structures of interest. Upon
addition of ligand to such mixtures at low molar
ratios, the Tm is shifted only for the nucleic acid con-
taining the preferred sequence or structure. Proof of
principle of the assay is provided using first a mix-
ture of polynucleotides with different sequences
and, second, with a mixture containing DNA, RNA
and two types of DNA:RNA hybrid structures.
Netropsin, ethidium, daunorubicin and actinomycin,
ligandswithknownsequencepreferences,wereused
to illustrate the method. The applicability of the
approach to oligonucleotide systems is illustrated
by the use of simple ternary and binary mixtures of
defined sequence deoxyoligonucleotides challenged
by the bisanthracycline WP631. The simple mixtures
describedhereprovideproofofprincipleoftheassay
and pave the way for the development of more soph-
isticatedmixturesforrapidlyscreeningtheselectivity
of new nucleic acid binding compounds.
INTRODUCTION
Nucleic acids are an important target for new therapeutic
agents (1–4). Two fundamental strategies exist for targeting
nucleic acids. The ﬁrst is to target speciﬁc sequences that
are vital for the control of gene expression (e.g. transcription
factor binding sites) with small molecule inhibitors (5–7). This
strategy has seen success with the development of sequence-
speciﬁc polyamides (6,8,9) and, more recently, with antigene
PNA molecules (10). A second strategy is to target non-
cannonical structures that may regulate gene activity. Daun-
orubicin and its synthetic enantiomer, for example, can act as
mutual allosteric effectors to switch DNA between right- and
left-handed forms (11). G-quadruplexes are of intense interest
as targets and have been implicated as important structural
elements in both the biology of telomeres and in the regulation
of gene expression (3,12,13). Small molecules that target
G-quadruplexes and that can regulate c-myc oncogene expres-
sion have recently been reported (14–18).
The evolution of new tools for the study of sequence- and
structural-selective ligand binding is important for efﬁcient
drug discovery. Chemical and enzymatic footprinting methods
revolutionized studies of sequence-selective recognition of
DNA by small molecules, enabling identiﬁcation of ligand
binding sites to base pair resolution (19–21). Competition
dialysis methods that allowed for rather precise inferences
of ligand base- and sequence-speciﬁcity actually predated
footprinting (22,23), but saw little application in part because
of the low-throughput nature of the assay. The competition
dialysis method was recently revived and expanded to provide
a rapid means of quantitatively evaluating ligand sequence-
and structural-selectivity by using an array of nucleic acid
samples (24–27). Thermal denaturation methods provide a
thermodynamically sound approach for quantifying drug–
nucleic acid interactions (28–31). Thermal denaturation is
especially powerful for the characterization of ligands with
ultratight binding afﬁnity (32). A rapid and frugal thermal
denaturation assay using molecular beacons was devised to
study ligand interactions with duplex, triplex and quadruplex
nucleic acids (33). While thermal denaturation methods are
powerful, rigorous and readily automated, they are hampered
by comparatively low-throughput. Samples are generally
run serially, and a typical melting curve takes several hours
to accumulate. Comparison of ligand binding with many
sequences or structures is thus time consuming.
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doi:10.1093/nar/gnj012We report a simple new thermal denaturation assay that
greatly facilitates comparison of ligand binding with different
nucleic acid sequences or structures. The assay is based on the
simple expediency of melting mixtures of polynucleotides
with different sequences or structures whose melting temper-
atures are well resolved. Addition of ligand to such mixtures
at appropriate molar ratios results in a shift of the melting
temperature of the nucleic acid containing the preferred
structure or sequence, providing a clear indication of ligand
selectivity. We provide proof of principle of the assay concept
for two cases, ﬁrst with mixtures to test sequence selectivity
and second with a mixture to test structural selectivity. The
applicability to oligonucleotide mixtures is also demonstrated.
We describe here assays that contain 4–5 sequences or struc-
tures. The concept is robust, however, and can potentially be
expanded to include large numbers of samples of particular
interest.
Additional comments concerning the strategy and design of
the assay are needed. Melting of nucleic acids in the presence
of ligands is complex (29,30). The apparent Tm shift has a
simple quantitative meaning only under conditions where the
nucleic acid lattice is fully saturated with ligand. At ligand
concentrations where the lattice is not fully saturated, melting
curves become multiphasic due to ligand redistribution, and
the shift in Tm has no simple interpretation or meaning. By
design, the assay described here utilizes low molar ratios of
ligand, where the lattice is far from saturation. This is opposite
from the typical experimental design usually used in melting
experiments (31), but is an essential condition for visualizing
sequence or structural selectivity. Sequence- or structural-
selective binding is most clearly manifested in the limit as
the binding ratio approaches zero (22,23). Our intent is to
provide an assay that provides a rapid, qualitative demonstra-
tion of selective binding, one that clearly shows a Tm shift for
the melting of the preferred nucleic acid. The assay is, by
design, optimized for demonstrating selectivity in binding
and is not intended to be used for quantitative analysis of
Tm shifts. Once the assay identiﬁes interesting types of select-
ive binding, rigorous biophysical studies can follow to char-
acterize the thermodynamics of binding quantitatively. The
situation is analogous to early footprinting methodologies
which focused on the qualitative identiﬁcation of preferred
binding sequences rather than on quantitative analysis of
binding afﬁnities.
MATERIALS AND METHODS
DNA sequence polynucleotides
[Poly(dA–dT)]2, Poly(dA)·poly (dT), Poly(dA–dC)·poly(dG–
dT), Poly(dC)·poly (dG) and [Poly(dC–dG)]2 were purchased
from Amersham Biosciences, Co. (Piscataway, NJ) and were
used without further puriﬁcation. Concentrations of nucleic
acid samples were determined by UV absorbance measure-
ments using the molar extinction coefﬁcients (expressed in
terms of phosphate) shown in Table 1. All polymer samples
were prepared in BPE/4 buffer (1.5 mM Na2HPO4, 0.5 mM
NaH2PO4, 0.25 mM Na2EDTA, pH ¼ 7.0). For preparation
of polynucleotide mixtures, equal molar concentrations
[typically 20–40 mM (bp)] of ﬁve polymers were added to
the desired volume of buffer solution.
Structural polynucleotides
Poly(dA) and poly(dT) were purchased from Amersham
Biosciences, Co. (Piscataway, NJ). Poly(rA) and Poly(U)
were purchased from Sigma Chemical Co (St Louis, MO).
These synthetic polynucleotides were used without further
puriﬁcation. Concentrations of nucleic acid samples were
determined by UV absorbance measurements using molar
extinction coefﬁcients (in terms of phosphate) of
8600 M
 1 cm
 1 at 257 nm for poly(dA), 8520 M
 1 cm
 1
at 264 nm for poly(dT), 9800 M
 1 cm
 1 at 258 nm for
poly(rA), 9350 M
 1 cm
 1 at 260 nm for poly(U), respectively.
To prepare DNA, RNA and DNA:RNA hybrid structures,
equimolar amounts of single-stranded polymers were mixed
with their complementary strand in BPES/4 buffer (1.5 mM
Na2HPO4, 0.5 mM NaH2PO4, 0.25 mM Na2EDTA and
46.25 mM NaCl, pH ¼ 7.0). Samples were heated at 90 C
for 3 min followed by slow cooling to room temperature.
Oligodeoxynucleotides
Synthetic 24 nt deoxyoligonucleotides, containing simple
CC/GG, AC/GT and AG/CT dinucleotide sequences were
purchased from Oligos Etc., Inc. (Wilsonville, OR). The
sequences and molar extinction coefﬁcient (expressed in
terms of strands) were listed in Table 1. These oligomers
were stored as concentrated stock solutions in water and
were diluted to working concentrations immediately before
use. For the preparation of double-stranded oligomers, equal
molar amounts of single-stranded deoxyoligonucleotides were
Table 1. Polynucleotide and oligonucleotide samples used
Mixture Nucleic acid l
(nm)
e
a
(M
 1 cm
 1)
Tm
( C)
Sequence
b [Poly(dA–dT)]2 262 6600 32.3
Poly(dA)·poly(dT) 260 6000 39.7
Poly(dA–dC)·poly(dG–dT) 258 6500 63.2
Poly(dC)·poly(dG) 253 7400 73.1
[Poly(dC–dG)]2 254 8400 87.8
Structure
c Poly(dA)·poly(dT) 260 6000 63.2
Poly(rA)·poly(rU) 260 7140 52.6
Poly(dA)·poly(rU) 257 6500 38.6
Poly(rA)·poly(dT) 260 6230 60
Oligonucleotide
d 1. T2 (CC)10 T2 +
T2 (GG)10 T2
260 133,148 51
260 270 478
2. T2 (AC)10 T2 +
T2 (GT)10 T2
260 197 120 63.9
260 237 000
3. T2 (AG)10 T2 +
T2 (CT)10 T2
260 263 907 71.9
260 185 789
aConcentration units of the extinction coefficient are expressed in terms
bases forpolynucleotides or strandsfor oligonucleotides. The molar extinction
coefficients for single-stranded oligonucleotides were determined by means of
a colorimetric phosphate assay (46).
bThe concentration of each polynucleotide in this mixture is 40 mM (bp). The
experiments were conducted in a buffer containing 1.5 mM Na2HPO4, 0.5 mM
NaH2PO4 and 0.25 mM Na2EDTA at pH 7.0.
cTheconcentrationofeachpolynucleotideis10mM(bp).Theexperimentswere
conductedinabuffercontaining1.5mMNa2HPO4,0.5mMNaH2PO4,0.25mM
Na2EDTA and 46.25 mM NaCl at pH 7.0.
dThe concentration of each oligonucleotide is 2 mM (strand). The experiments
wereconductedinabuffercontaining6mMNa2HPO4,2mMNaH2PO4,1mM
Na2EDTAand 185 mM NaCl at pH 7.0.
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(6 mM Na2HPO4, 2 mM NaH2PO4, 1 mM Na2EDTA and
0.185 M NaCl, pH ¼ 7.0). Subsequently, the mixtures were
heated at 90 C for 3 min followed by slow cooling to room
temperature prior to the melting experiments.
Ligands
Ethidium bromide, daunomycin and actinomycin D were pur-
chased from Sigma Chemical Co. Netropsin was purchased
from Serva Feinbiochemica (Heidelberg, Germany). The
structures of the ligands are shown in Figure 1. WP631 was
purchased from EMD Biosciences, Inc. Ligands were used
without further puriﬁcation and prepared in distilled water
and stored at  20 C. Drug concentrations were determined
spectophotometrically.
Thermal denaturation assay
A Jasco V-550 UV/Vis (Tokyo, Japan) spectrophotometer
equipped with a thermoelectric temperature controller was
used to obtain thermal denaturation data. One centimeter path-
length quartz cuvettes with Teﬂon stoppers were used. All
sample mixtures were fully equilibrated at room temperature
following addition of ligand and were subsequently heated
over the range of 20–98 C at a rate of 1 C/min while the
absorbance was continuously monitored at 260 nm. Primary
data were transferred to the graphics program Origin
(Microcal, Inc.) for plotting and analysis.
Competition dialysis
Competition dialysis experiments were carried out as
described previously (24–27). The experiments were carried
out in BPES buffer consisting of 6 mM Na2HPO4, 2m M
NaH2PO4, 1 mM Na2EDTA and 0.185 M NaCl (pH 7.0).
Nucleic acid samples including four different structures
(volume of 200 ml at identical concentration of 75 mM bp)
were dialyzed against 200 ml dialysate containing 1 mM
netropsin or ethidium.
RESULTS AND DISCUSSION
Assay for sequence selectivity
An assay for base and sequence selectivity was devised
by preparing an equimolar mixture of [Poly(dA–dT)]2,
Poly(dA)·poly (dT), Poly(dA–dC)·poly(dG–dT), Poly(dC)·
poly(dG) and [Poly(dC–dG)]2. The Tm values of these
duplexes are well separated (Table 1). Collectively, the poly-
nucleotide mixture contains eight of the ten unique dinuc-
leotide steps (AA ¼ TT, AT, TA, AC, CA, GG ¼ CC, GC,
CG), and eight of the 32unique triplet sequences (AAA,GGG,
ATA, TAT, GCG, CGC, ACA, CAC). Figure 2 shows the
results of addition of the compounds shown in Figure 1 to
the mixture. Low molar ratios of compound ( 0.01 drug/bp)
were added to the mixture because such conditions are optimal
for the selection of a particular binding site from the mixture.
Netropsin (Figure 1A) shows a clear preference for binding to
poly(dA)·poly (dT) and to a lesser extent, [poly(dA–dT)]2
(Figure 2A), as is evident from the shifts in peaks 2 and 1.
This result is fully consistent with the known preference of
this groove binder for AT-rich sequences revealed in the very
ﬁrst footprinting studies (19,21). Competition dialysis also
revealed the strong preference of netropsin for [Poly(dA–
dT)]2 and Poly(dA)·poly (dT), along with a general preference
for AT-rich natural DNA samples (25).
We emphasize here that, by design, the assay uses a single,
low molar ratio of added ligand, conditions that maximize the
manifestation of selective binding. Supplementary Figure 1
shows the effects of increasing the molar ratio of netropsin
on the melting of the polynucleotide mixture. As can be seen
in that ﬁgure, as the concentration of netropsin increases, the
Tm values for the melting of the two AT containing poly-
nucleotides increases, but that less speciﬁc binding to the
remaining three polynucleotides also becomes evident. Such
behavior is to be expected as the increased free ligand con-
centration drives the weaker, non-speciﬁc binding to the less
preferred sequences.
Ethidium (Figure 1B) is widely, but erroneously, thought to
lack sequence selectivity. It can, in fact, discriminate between
sequences as revealed in low-temperature footprinting experi-
ments (34). From an analysis of the changes in patterns of
digestionbyDNAase I,FoxandWaringdeducedthatethidium
binds best to regions of mixed nucleotide sequence, especially
those containing alternating purines and pyrimidines. Exactly
that preference is revealed in Figure 2B. Tm shifts are evident
for only poly(dA–dC)·poly(dG–dT) and [Poly(dC–dG)]2.
The anticancer agent daunorubicin (Figure 1C) binds
preferentially (but not exclusively) to triplet sequences in
which an AT base pair is ﬂanked by adjacent GC base
pairs (35–37). Daunorubicin shows a general preference for
GC-rich DNA with an alternating purine-pyrimidine sequence
(22). Such preferences are observed in Figure 2C, where
daunomycin elevates the Tm of poly(dA–dC)·poly(dG–dT)
and [Poly(dC–dG)]2.
Actinomycin binds selectively to 50GpC steps in
duplex DNA (19,21,38). That sequence preference is clearly
observed in Figure 2D, where actinomycin only alters the Tm
of [Poly(dC–dG)]2.
Collectively, the data shown in Figure 2 conﬁrm the utility
of the melting of mixtures assay. The results obtained are
fully consistent with the known sequence preferences of the
Figure 1. Structures of compounds used for melting studies. (A) Netropsin,
(B) ethidium, (C) daunorubicin and (D) actinomycin D.
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are signiﬁcant advantages of the thermal denaturation assay
over both footprinting and competition dialysis methods.
Both footprinting and dialysis are time consuming, with at
least 24 h needed in each case to execute the experiment
and process the data. Competition dialysis, in its simplest
form, requires that ligands possess convenient absorbance
or ﬂuorescence signals for concentration determinations.
The thermal denaturation assay described here requires no
signal from the ligand and can be completed in a few hours
with real-time data display. As a standard spectrophotometric
assay, the method is clearly amenable to automation and
multiplexing.
We caution that, by design, the absolute values of Tm shift
in this assay are not of primary importance in this assay, and
in fact have no simple quantitative meaning. The conditions of
the assay are such that the nucleic acid lattice is not saturated
by ligand, consequently melting curves in the presence of
ligand are expected to be broad and multiphasic (29,30). Non-
etheless, the shift in Tm unambiguously reports the binding to
the most preferred nucleic acid sequence.
Oligonucleotide-based assay
Figure 3 shows results for a simple oligonucleotide-based
assay. The polynucleotide assay for sequence selectivity is
hampered by the availability of all desired sequences. Deoxy-
oligonucleotides of any desired sequence can be synthesized,
imparting great ﬂexibility in the design of sequence mixtures
for speciﬁc purposes. A potential disadvantage of an oligo-
nucleotide assay is in the width of the individual melting
transitions, which may adversely affect the resolution of melt-
ing temperatures. Figure 3, however, provides encouraging
proof of principle.
Figure 3A shows the melting of three 24 bp designed
duplexes, T2 (CC)10 T2 ·T 2 (GG)10 T2,T 2 (AC)10 T2 ·T 2
(GT)10 T2 and T2 (AG)10 T2 ·T 2 (CT)10 T2, whose Tm values
are, respectively, 51, 63.9 and 71.9 C. Figure 3B (black line)
shows a mixture of these three duplexes. The peak positions
are lowered relative to panel A because of a decrease in duplex
concentration from 2 to 0.67 mM. The melting transitions of
the three duplexes remain well resolved in the mixture. Upon
addition of the bisdaunorubicin WP631 (Figure 3B, dashed
line), melting of T2 (CC)10 T2 ·T 2 (GG)10 T2 is unaltered,
while the melting temperatures of both T2 (AC)10 T2 ·T 2
(GT)10 T2 and T2 (AG)10 T2 ·T 2 (CT)10 T2 are increased.
WP631 clearly prefers the sequences with mixed AT/GC
composition. There is a greater increase in the Tm of the
AG sequence, suggesting that a nonalternating purine-
purine arrangement is preferred over an alternating purine-
pyrimidine sequence. Results using a binary mixture of
T2 (AC)10 T2 ·T 2 (GT)10 T2 and T2 (AG)10 T2 ·T 2 (CT)10
T2 conﬁrm that conclusion (Figure 3C). The results in
Figure 3C indicate that WP631 can selectively stabilize the
purine-purine sequence at low molar ratios where binding
preferences are most clearly manifested.
Figure 2. Sequence selectivity revealed by melting studies of polynucleotide mixtures. Each panel shows the melting of a mixture of [poly(dA–dT)]2 (peak 1),
poly(dA) poly(dT) (peak 2), poly(dA–dC) poly(dG–dT) (peak 3), poly(dG) poly(dC) (peak 4) and [poly(dG–dC)2 (peak 5) as the solid black line. The con-
centration of each polynucleotide is 40 mM (bp); total polynucleotide concentration is 200 mM (bp). The dashed line in each panel shows the effect of additions
of lowmolarratiosof eachof thecompoundsshownin Figure1. Thearrows indicatethe peaksthatare alteredby additionof thecompound.(A) Netropsinat 2mM;
(B) ethidium at 2 mM; (C) daunorubicin at 2 mM; (D) actinomycin D at 1.5 mM.
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utility for studies of sequence selectivity. Simple binary and
ternary mixtures were deliberately chosen to illustrate the
potential of the method. There is no reason to prevent exten-
sion of the method to more complicated mixtures. The advant-
age of the oligonucleotide system is that any sequences of
interest can be synthesized and studied. Minor disadvantages
are that the width of oligonucleotide melting transitions
adversely affects resolution, and melting temperatures are
more dependent upon strand concentration than is the case
for polynucleotides.
Assay for structural selectivity
A mixture was made to study ligand selectivity for four dif-
ferent structures, DNA, RNA and two types of DNA:RNA
hybrids. In this mixture, DNA is represented by poly(-
dA)·poly(dT), RNA by poly(rA)·poly(rU), hybrid I by poly(-
dA)·poly(rU) and hybrid II by poly(rA)·poly(dT). DNA:RNA
hybrids are structures of profound biological importance and
are an emerging target for drug design efforts (39–41). Results
are shown in Figure 4.
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Figure 4. Structural selectivity revealed by melting studies of polynucleotide
mixtures. Each panel shows the melting of a mixture of DNA [poly(dA)·poly
(dT); peak 4], RNA [poly(rA) poly (rU); peak 2], a DNA:RNA hybrid [poly
(dA) poly(rU);peak1]andanRNA:DNAhybrid[poly(rA) poly(dT);peak3]
as the solid black line. The concentration of each polynucleotide structure was
10 mM (bp); total polynucleotide concentration is 40 mM (bp). The dashed line
in each panel shows the effect of addition of ligand. (A). Netropsin at 1.6 mM.
(B) Ethidium at 1.5 mM. (C) A semi-synthetic derivative of the natural product
b-lapachone (45) at 5 mM.
Figure 3. Melting of deoxyoligonucleotide mixtures. (A). Melting of
(T2G20T2)  (T2C20T2) (black line), (T2(AC)10T2)  (T2(GT)10T2) (dashed line)
and (T2(AG)10T2)  (T2(CT)10T2) (dotted line). All samples were at 2 mM
duplexconcentration. (B).Meltingofa mixtureofthe threedeoxyoligonucleo-
tides in (A) in the absence (black line) or presence (dashed line) of the bisan-
thracycline WP631 (32). Each deoxynucleotide in the mixture was at a
concentration of 0.67 mM duplex, for a total duplex concentration of 2 mM.
WP631 was add to a final concentration of 1.6 mM. (C). Melting of a binary
mixture (4 mM total duplex) of (T2(AC)10T2)  (T2(GT)10T2) and
(T2(AG)10T2)  (T2(CT)10T2) alone (black line) or in the presence of 1.6 mM
WP631 (dashed line).
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preference for DNA as represented by poly(dA)·poly(dT),
as was expected. Netropsin is known to convert non-
B-DNA structures back to a standard B-form that contains
the preferred minor groove geometry to which it binds most
avidly (42,43). Netropsin does not bind to A-form RNA (44).
Competition dialysis (Figure 5A) was used to conﬁrm the
structural preference of netropsin to validate the results of
the melting mixture assay.
Ethidium was previously shown by competition dialysis to
bind preferentially to an RNA:DNA hybrid structure (40).
Figure 4B shows that same preference in the melting assay.
Ethidium shifts the Tm of poly(rA)·poly(dT), but does not
appreciably alter the melting temperatures of any other poly-
nucleotides in the mixture at the molar ratio added. Competi-
tion dialysis experiments (Figure 5B) validate the structural
preference observed in the melting assay.
With the melting assay validated by netropsin and ethidium,
an unknown compound was studied to illustrate the utility of
the method. A derivative of the natural product b lapachone
(45) clearly shows a strong preference for the DNA:RNA
hybrid poly(dA)·poly(rU) (Figure 4C). That is a wholly novel
type of nucleic acid structural recognition that is under
detailed biophysical study in our laboratory. The tantalizing
result is shown here only to illustrate the utility of method.
A more complete biophysical study of this unusual binding
interaction hasbeen completed and willbe reported elsewhere.
SUMMARY AND CONCLUSIONS
New types of thermal denaturation assays were described for
the study of sequence- and structural-selective nucleic acid
binding. Mixtures of polynucleotides or oligonucleotides of
different sequences or structures with well-resolved melting
temperatures can be prepared and subjected to thermal denat-
uration. Addition of ligands at low molar ratios results in
elevation of the Tm of the polynucleotide with the most pre-
ferred sequence or structure. The advantages of the assay are
many. The assay is simple, direct, inexpensive and rapid. As a
spectrophotometric assay, the method is amenable to automa-
tion and multiplexing. Proof of principle of the method was
provided here with simple mixtures that are nonetheless
complicated enough to be interesting. The composition of
the mixtures can be designed in accord with the particular
interests of the investigator and with regard to the nucleic
acid being targeted. Simple 3 to 5 component mixtures
were described here, but there is no reason to prevent the
design of more complex mixtures to provide more stringent
tests of selectivity.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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